WHO WE ARE

ABOUT GLOBAL LIVER INSTITUTE

Driving collaboration to improve liver health and eliminate liver disease worldwide.

MISSION

To improve the lives of individuals and families impacted by liver disease through promoting innovation, encouraging collaboration, and scaling optimal approaches to help eradicate liver diseases.

VISION

For liver health awareness to be universal and for liver disease to take its proper place on the global public health agenda consistent with its prevalence and impact.

VALUES

Patient-centeredness

Collaboration

Integrity

Inclusion

Results

BOARD OF DIRECTORS

Victor J. Reyes, MBA

GLI Board Chair
Managing Director, Human Capital, Deloitte Consulting LLP

Brian Munroe

GLI Board Treasurer
Vice President Government Affairs at Bausch Health Companies Inc.

Laurie Mobley

GLI Board Development Co-Chair
Senior Vice President, BRG Communications

Nicholas Austin, JD

Principal Corporate Legal Counsel, Microsoft, Inc.

Gary Deverman, CFRE

Vice President, NutriStyle

Ben Goodman

Maine Dept of Economic and Community Development Liaison for Legislative Policy and External Communication

Larry R. Holden

President & Chief Executive Officer, Global Liver Institute

Melodie Narain

President & Founder, Color of Crohn’s & Chronic Illness

All members of the Board of Directors sign an agreement to adhere to GLI’s Conflict of Interest Policy. View our policy here.

Patient & Scientific Advisory Council

Patient and Scientific Advisory
Council Founding Members

Launched in 2025, our Patient & Scientific Advisory Council brings together a diverse group of leaders in liver health — both patients and clinical experts — to guide GLI's education, advocacy, and training initiatives. By combining real-world insights with scientific rigor, the Council helps ensure that GLI's efforts remain relevant, evidence-based, and aligned with the current needs of the field and community.

Arun Sanyal, MD

Arun Sanyal, MD

Professor of Medicine,
Hepatology Expert

Ash Kyasima-Migadde

Ash Kyasima-Migadde

Patient Advocate &
Community Leader

Karen Hoyt

Karen Hoyt

Hepatitis C Survivor &
Patient Voice Leader

Lionel A. Kankeu Fonkoua, MD

Lionel A. Kankeu Fonkoua, MD

Oncologist,
Liver Cancer Specialist

Manuel Rodriguez-Davalos, MD

Manuel Rodriguez-Davalos, MD

Transplant Surgeon
& Researcher

Melaine D. Smith

Melaine D. Smith

MASH Patient Leader
& Educator

Saima Ajaz, PhD

Saima Ajaz, PhD

Research Scientist,
Liver Disease Genetics

Stephen Silva-Brave, LMSW

Stephen Silva-Brave, LMSW

Licensed Social Worker
& Patient Advocate

Terry D. Box, MD

Terry D. Box, MD

Pediatric Hepatologist

Wendy Lo

Wendy Lo

Rare Disease
Patient Advocate

Contributors

Proud to partner with organizations advancing liver health globally

Alexion Pharmaceuticals
Altimmune
AstraZeneca
BioMarin BioMarin
Boehringer Ingelheim
Bristol Myers Squibb
Cancer Support Community
Eisai
Pharmacy Times
Alexion Pharmaceuticals
Altimmune
AstraZeneca
BioMarin BioMarin
Boehringer Ingelheim
Bristol Myers Squibb
Cancer Support Community
Eisai
Pharmacy Times